Harry Paul Erba
Professor of MedicineOverview
I am a clinical investigator in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine. I serve as Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies. I am also the Chair of the SWOG Leukemia Committee. I am interested in the clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia. Specifically, I have been the Principal Investigator for small molecular inhibitors, antibody-drug conjugates and cytotoxic chemotherapy.
Positions
Professor of Medicine in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2018 School of Medicine
Education
Ph.D. 1988
1988 Stanford University
M.D. 1988
1988 Stanford University, School of Medicine
Licensure 2012
2012 Medical Licensure Commission of Alabama
Clinical Fellow in Medicine, MEDICINE
1991 Harvard Medical School
Residency Physician, MEDICINE
1990 Brigham and Women's Hospital
Research Fellowship in Medicine, MEDICINE
1993 Harvard Medical School
Research/Clinical Fellowship in Medicine, MEDICINE
1992 Brigham and Women's Hospital
Publications, Grants & Awards
DCI Centers, Cancer Types & Labs
Offices & Contact
2400 Pratt St Suite 5000
Durham, NC
27710
DUMC Box 3961
Durham, NC
27710